Approvals/CIMA-AEMPS/SITAGLIPTINA/METFORMINA SWANPOND INVESTMENTS 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

SITAGLIPTINA/METFORMINA SWANPOND INVESTMENTS 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Swan Pond Investments Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 9223ad63d79032a7
Drug Cima Aemps Name: SITAGLIPTINA/METFORMINA SWANPOND INVESTMENTS 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 88316
Holder Company Name: Swan Pond Investments Limited
Marketing Company Name: Swan Pond Investments Limited
Authorization Date: 2022-11-25
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 50/1000 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Swan Pond Investments Limited

SITAGLIPTINA MALATO

66,45 mg

METFORMINA HIDROCLORURO

1000 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 25, 2022

Approval ID

9223ad63d79032a7

Type

Standard